Published in Neurology on September 22, 1999
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol (2012) 3.96
Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol (2006) 1.86
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up. Neuro Oncol (2006) 0.87
Oligodendroglioma. Curr Treat Options Neurol (2001) 0.82
Oligodendroglioma. Curr Treat Options Neurol (2005) 0.77
Procarbazine, Lomustine, and Vincristine (PCV) Regimen for Central Nervous System Tumors. Hosp Pharm (2017) 0.75
Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol (1990) 18.71
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst (1998) 5.30
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer (2000) 4.96
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol (2004) 4.46
Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med (1982) 3.27
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2000) 2.32
Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res (2001) 2.28
Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol (1990) 2.24
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol (2011) 2.13
Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. J Neurosurg (2000) 1.82
Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg (1991) 1.81
Radiation therapy for brain metastases. Ann Neurol (1980) 1.68
Glioma classification: a molecular reappraisal. Am J Pathol (2001) 1.65
Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol (1988) 1.64
Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsets. Proc Natl Acad Sci U S A (1982) 1.59
Malignant glioma: who benefits from adjuvant chemotherapy? Ann Neurol (1998) 1.56
Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys (1992) 1.54
Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol (1999) 1.52
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology (2011) 1.48
PCV for oligodendroglial tumors: in search of prognostic factors for response and survival. Can J Neurol Sci (2001) 1.47
Measuring bias in uncontrolled brain tumor trials--to randomize or not to randomize? Can J Neurol Sci (1997) 1.43
Oligodendroglioma. Cancer Invest (1996) 1.39
Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res (2001) 1.38
Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol (1990) 1.35
Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys (2000) 1.32
Chemotherapy of brain tumors. Arch Neurol (1977) 1.29
Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg (1989) 1.27
The lateral recess syndrome. A variant of spinal stenosis. J Neurosurg (1980) 1.25
Permeability of different experimental brain tumor models to horseradish peroxidase. J Neuropathol Exp Neurol (1982) 1.24
Microvascular abnormalities in virally-induced canine brain tumors. Structural bases for altered blood-brain barrier function. J Neurol Sci (1972) 1.22
Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys (1999) 1.18
Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell line. Biochem Biophys Res Commun (1985) 1.16
Dapsone and peripheral motor neuropathy. Arch Dermatol (1969) 1.16
Long-term glioblastoma multiforme survivors: a population-based study. Can J Neurol Sci (1998) 1.15
Identification of glial filament protein and vimentin in the same intermediate filament system in human glioma cells. Proc Natl Acad Sci U S A (1984) 1.14
Corticosteroid-induced magnetic resonance imaging changes in patients with recurrent malignant glioma. J Clin Oncol (1994) 1.14
Monoclonal antibodies to three widely distributed human cell surface antigens. Hybridoma (1983) 1.14
p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J Natl Cancer Inst (1994) 1.13
Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology (1991) 1.13
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. J Clin Oncol (1998) 1.12
The role of the subependymal plate in glial tumorigenesis. Acta Neuropathol (1977) 1.12
An intermediate filament-associated protein, p50, recognized by monoclonal antibodies. J Cell Biol (1983) 1.11
Primary cerebral fibrosarcomas. Clinicopathologic study and review of the literature. Cancer (1993) 1.06
Postoperative contrast enhancement in patients with brain tumor. Ann Neurol (1985) 1.05
Syncope from head and neck cancer. J Neurooncol (1983) 1.05
Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas. Int J Radiat Oncol Biol Phys (2001) 1.04
PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Am J Pathol (2001) 1.04
A skeletal-muscle disorder associated with intermittent symptoms and a possible defect of lipid metabolism. N Engl J Med (1970) 1.04
Pleomorphic xanthoastrocytoma. Ultrastructural and immunohistochemical study of a case with a rapidly fatal outcome following surgery. Cancer (1983) 1.04
Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg (1994) 1.03
Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature. Neurology (1991) 1.03
Neuroradiological evaluation of lateral recess syndrome. Radiology (1981) 1.02
Regional measurements of blood flow in experimental RG-2 rat gliomas. Cancer Res (1983) 1.01
Steroid-induced CT changes in patients with recurrent malignant glioma. Neurology (1988) 0.99
Diffuse sclerosis with adrenal insufficiency. Neurology (1968) 0.99
Regional measurements of blood-to-tissue transport in experimental RG-2 rat gliomas. Cancer Res (1983) 0.97
Acute transverse myelitis due to Mycoplasma pneumoniae infection. Arch Neurol (1981) 0.94
Wernicke's encephalopathy: an experimental study in the rhesus monkey. Acta Neuropathol (1975) 0.94
Chemotherapy for malignant gliomas. Baillieres Clin Neurol (1996) 0.94
Primary diffuse leptomeningeal oligodendroglioma. Case report. J Neurosurg (1995) 0.94
Selection bias in clinical trials of anaplastic glioma. Ann Neurol (1989) 0.94
Chemotherapy for brain tumors. Oncology (Williston Park) (1998) 0.93
Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res (2000) 0.93
Selection bias, survival, and brachytherapy for glioma. J Neurosurg (1992) 0.93
Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res (2001) 0.91
Bilateral superior laryngeal neuralgia: its successful treatment with carbamazepine. Arch Neurol (1980) 0.90
Aggressive oligodendroglioma: a chemosensitive tumor. Neurosurgery (1992) 0.90
Homozygous deletions of the CDKN2C/p18INK4C gene on the short arm of chromosome 1 in anaplastic oligodendrogliomas. Brain Pathol (1999) 0.90
Post-surgical contrast enhancement mimicking residual brain tumour. Can J Neurol Sci (1985) 0.89
Comparison of metastatic properties of a variety of mouse, rat, and human cells in assays in nude mice and chick embryos. In Vivo (1991) 0.89
Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. Neurosurgery (1986) 0.89
Demyelinating radiculopathy in the Kearns-Sayre syndrome: a clinicopathological study. Ann Neurol (1980) 0.89
Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results. Clin Cancer Res (1996) 0.88
Treatment of oligodendroglioma: an update. Neuro Oncol (1999) 0.88
Experimental gliomas: an autoradiographic study of the endothelial component. Neurology (1980) 0.88
Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group Trial 9507. J Clin Oncol (2001) 0.88
Chemotherapy for oligodendroglioma. Progress report. Arch Neurol (1991) 0.87
A mechanism underlying the lack of a blood-brain barrier to peroxidase in virally induced brain tumors. J Neuropathol Exp Neurol (1971) 0.87
Malignant glioma--timing of response to radiation therapy. Int J Radiat Oncol Biol Phys (1993) 0.87
The fine structure of canine gliomas and intracranial sarcomas induced by the Schmidt-Ruppin strain of the Rous sarcoma virus. J Neuropathol Exp Neurol (1971) 0.87
Comparative permeability of different glioma models to horseradish peroxidase. Cancer Treat Rep (1981) 0.87
Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas. J Clin Oncol (1997) 0.87
Growth rate of non-operated meningiomas. J Neurol (2008) 0.85
A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1994) 0.85